08182017Headline:

New York City, New York

HomeNew YorkNew York City

Email Staff Writer Staff Writer on LinkedIn Staff Writer on Twitter Staff Writer on Facebook
Staff Writer
Staff Writer
Contributor •

FDA wants more warnings on Paxil labels

Comments Off

A report from AssociatedContent.com says that the Food and Drug Adminstration (FDA) has recently proposed the idea of drug makers putting more label warnings of Paxil and other antidepressant drugs for those under age 25.

The reason for this stems from studies that show an increase in suicidal thoughts when people under age 25 take antidepressant drugs such as Paxil. Apparently GlaxoSmithKline, manufacturer of Paxil, and the FDA said in May 2006 that Paxil caused an increase in suicidal thoughts among its younger users.

The FDA reviewed 372 studies with 100,000 patients and 11 antidepressants. They concluded that young adults needed to be closely monitored if place on the drugs, particularly during the first two months of the drug being introduced to the system. That was based on the fact that there were elevated suicidal thoughts and actions in those ages 24 and younger.

90 million prescriptions for antidepressants are written each year. Many have charged that America is overmedicated and that doctors are just dispensing out antidepressants for anyone that asks without regard to their necessity.

Paxil has also been known to cause birth defects and other adverse side effects in those who use it. If you or someone you know has experienced adverse side effects while using Paxil or another drug, it may be in your best interest to consult an attorney. Click on the form to the right for a free case evaluation.